Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUHRS: Teriparatide in Hip Replaced Subjects
NCT00191321Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of teriparatide in osteoporosis, sponsored by Eli Lilly and Company. Primary endpoints: C-terminal telopeptide of type I collagen at 18 months, Procollagen type I N-terminal propeptide at 18 months and 1 more. Started Jul 2004; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00191321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191321.